Synthetic biology researchers unveiled a cell-free enzymatic manufacturing platform capable of synthesizing mRNA and recombinant protein vaccines in a fraction of the time required by conventional bioreactor systems. The method allows rapid antigen formulation during emerging pathogen outbreaks.
Vaccinologists emphasize that decentralized, cell-free production could democratize global vaccine manufacturing by allowing regional health centers to produce targeted immunization doses on-demand.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.news2026.example.com/vaccine-tech-4